Schedule 13D ownership disclosure

TALARIS THERAPEUTICS INC

Security class unavailable · CUSIP: 87410C104

Event date: 2021-05-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,831,774
Percent of class
4.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-028059
Form type
SC 13D
Filer
Qiming U.S. Healthcare GP II, LLC
CIK
CIK 1868862
Filed
Feb 28, 2022
Reporting period
May 11, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub